24358-84-7 (地昔卡因,(S)-Mepavacaine)

地昔卡因;

2-Piperidinecarboxamide,N-(2,6-dimethylphenyl)-1-methyl-, (2S)-;(2S)-N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;( )-1,2',6'-Trimethyl-2-piperidincarboxanilid;(+)-1-Methyl-2',6'-pipecoloxylidide;(+)-Mepivacaine;(2S)-N-(2,6-dime;(S)-Mepivacaine;2',6'-Pipecoloxylidide, 1-methyl-, (+)- (8CI);2',6'-Pipecoloxylidide, 1-methyl-, L-(+)-;2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, (S)-;Dexivacain;Dexivacaina;Dexivacaina [INN-Spanish];Dexivacaine [USAN:INN];Dexivacainum;Dexivacainum [INN-Latin];L(+)-Mepivacaine;UNII-QI846AL4NC;CS-0078837;(2S)-N-(2, 6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;5-22-01-00223 (Beilstein Handbook Reference);HY-119961;QI846AL4NC;2',6'-Pipecoloxylidide, 1-methyl-, (+)-;CHEMBL2104634;(+)-1,2',6'-Trimethyl-2-piperidincarboxanilid;Q27287277;DEXIVACAINE;Dexivacaine (USAN/INN);AKOS040751539;DEXIVACAINE [USAN];(S)-N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;BRN 0211230;L-(+)-MEPIVACAINE;DTXSID30179091;DEXIVACAINE [INN];EN300-18562930;SCHEMBL25315;NS00098815;2-PIPERIDINECARBOXAMIDE, N-(2,6-DIMETHYLPHENYL)-1-METHYL-, (2S)-;Mepivacaine, (s)-;D03719;(+)-1-METHYL-2',6'-PIPECOLOXYLIDIDE.;ROPIVACAINE HYDROCHLORIDE MONOHYDRATE IMPURITY C [EP IMPURITY];(S)-Mepavacaine;(Z,2S)-N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboximidic acid;24358-84-7;

INWLQCZOYSRPNW-ZDUSSCGKSA-N

1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)/t13-/m0/s1

O=C([C@@H]1CCCCN1C)NC1C(C)=CC=CC=1C